First, to our knowledge, this is the first study to demonstrate that MCL-1, an anti-apoptotic gene crucial for chemoresistance in colorectal cancer, undergoes dose-dependent downregulation in butyrate-treated CRC cells. Here, MCL1 is linked to colorectal carcinoma.